Market Cap 14.13M
Revenue (ttm) 28.51M
Net Income (ttm) -26.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -92.60%
Debt to Equity Ratio 0.00
Volume 193,200
Avg Vol 127,920
Day's Range N/A - N/A
Shares Out 11.78M
Stochastic %K 57%
Beta 1.63
Analysts Strong Sell
Price Target $5.00

Company Profile

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-resu...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 858 888 7600
Website: bionano.com
Address:
9540 Towne Centre Drive, Suite 100, San Diego, United States
JumpStarting
JumpStarting Aug. 21 at 4:11 PM
$BNGO Another important development is reimbursement. CMS increased the 2026 payment determination associated with OGM testing for hematologic malignancies by 47%, improving the economics of clinical adoption. Can Bionano turn OGM into a recurring, increasingly reimbursed clinical testing platform with growing consumables utilization? This is a turnaround worth watching.
0 · Reply
JumpStarting
JumpStarting Aug. 21 at 4:04 PM
$BNGO The flow-cell numbers are particularly interesting. The Saphyr/OGM system is the equipment, but the flow cells are recurring consumables. If laboratories continue increasing their utilization of OGM, BNGO can potentially generate recurring revenue from an installed customer base rather than relying entirely on selling new instruments. And the opportunity isn't limited to one disease. OGM has applications in hematologic cancers, rare genetic disorders, muscular diseases, oncology research, reproductive genetics and cell/gene therapy.
0 · Reply
JumpStarting
JumpStarting Aug. 21 at 3:57 PM
$BNGO Is This the Beginning of the Turnaround? Q2 2026 showed: Revenue of $8.2M, up 21% year over year Consumables revenue of $4.3M, up 31% 9,219 flow cells sold, up 27% Existing-customer flow-cell purchases increased 24% Gross margin reached 53% BNGO fully retired its $20M secured convertible debt 2026 revenue guidance remains $31–33M
0 · Reply
vaccigen
vaccigen Aug. 20 at 12:30 AM
$BNGO Is the 5 cent hike to lure new investors?
1 · Reply
sloshua
sloshua Aug. 19 at 1:54 PM
0 · Reply
Dennizz
Dennizz Aug. 17 at 1:19 PM
$PGABF 🇺🇸 Could this be one of Europe’s most overlooked MedTech microcaps? $PGABF A tiny Swedish precision-medicine company Prostatype valued at only $5 million has developed a fully commercialized genomic test for prostate cancer, and is now awaiting a potentially transformational Medicare reimbursement decision in the U.S before year end🔥 $BNGO $INO $TNXP $ATOS.X
1 · Reply
juanagustin2086
juanagustin2086 Aug. 15 at 6:29 AM
1 · Reply
Marcobecco
Marcobecco Aug. 13 at 3:42 PM
0 · Reply
tokenhead
tokenhead Aug. 13 at 1:48 AM
$BNGO yes fuc ski boy..
0 · Reply
Snow120
Snow120 Aug. 12 at 6:09 PM
$BNGO where is motherfucking Erik? He is still CEO ???? Fuck him 🖕🏻🖕🏻🖕🏻🖕🏻
0 · Reply
Latest News on BNGO
Bionano Genomics Earnings Call Transcript: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 12 days ago

Bionano Genomics Earnings Call Transcript: Q2 2026


Bionano Genomics Earnings release: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 12 days ago

Bionano Genomics Earnings release: Q2 2026


Bionano Genomics Quarterly report: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 12 days ago

Bionano Genomics Quarterly report: Q2 2026


Bionano Genomics Slides: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 12 days ago

Bionano Genomics Slides: Q2 2026


Bionano Announces Hiring of Chief Scientific Officer

Jun 24, 2026, 8:30 AM EDT - 2 months ago

Bionano Announces Hiring of Chief Scientific Officer


Bionano Genomics Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

Bionano Genomics Earnings Call Transcript: Q1 2026


Bionano Genomics Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

Bionano Genomics Earnings release: Q1 2026


Bionano Genomics Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

Bionano Genomics Quarterly report: Q1 2026


Bionano Genomics Slides: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

Bionano Genomics Slides: Q1 2026


Bionano Genomics files $400M mixed securities shelf

2026-05-08T23:01:48.000Z - 3 months ago

Bionano Genomics files $400M mixed securities shelf


Bionano Genomics Registration statement: Registration filing

May 8, 2026, 8:00 AM EDT - 3 months ago

Bionano Genomics Registration statement: Registration filing


Bionano Announces Leadership Transition

May 6, 2026, 4:30 PM EDT - 3 months ago

Bionano Announces Leadership Transition


Bionano Genomics Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 5 months ago

Bionano Genomics Proxy statement: Proxy filing


Bionano Genomics Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 5 months ago

Bionano Genomics Proxy statement: Proxy filing


Bionano Genomics Earnings Call Transcript: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 5 months ago

Bionano Genomics Earnings Call Transcript: Q4 2025


Bionano Genomics Annual report: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 5 months ago

Bionano Genomics Annual report: Q4 2025


Bionano Genomics Earnings release: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 5 months ago

Bionano Genomics Earnings release: Q4 2025


Bionano Genomics Slides: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 5 months ago

Bionano Genomics Slides: Q4 2025


Bionano Genomics reports Q4 revenue $7.95M vs. $8.16M last year

2026-03-23T20:16:27.000Z - 5 months ago

Bionano Genomics reports Q4 revenue $7.95M vs. $8.16M last year


Bionano Genomics sees Q1 revenue $6.5M-$6.7M

2026-03-23T20:15:56.000Z - 5 months ago

Bionano Genomics sees Q1 revenue $6.5M-$6.7M


Bionano Genomics announces Bionano Symposium Day 4 highlights

2026-02-27T13:11:08.000Z - 6 months ago

Bionano Genomics announces Bionano Symposium Day 4 highlights


Bionano Genomics announces Bionano Symposium Day 3 highlights

2026-02-26T13:37:50.000Z - 6 months ago

Bionano Genomics announces Bionano Symposium Day 3 highlights


Bionano Genomics announces Bionano Symposium Day 1 highlights

2026-02-24T13:11:39.000Z - 6 months ago

Bionano Genomics announces Bionano Symposium Day 1 highlights


Bionano Genomics announces Bionano Symposium 2026

2026-02-09T14:10:50.000Z - 6 months ago

Bionano Genomics announces Bionano Symposium 2026


Bionano Genomics reports preliminary Q4 revenue $7.8M-$8M

2026-01-12T13:17:13.000Z - 7 months ago

Bionano Genomics reports preliminary Q4 revenue $7.8M-$8M


Bionano Genomics recaps advances in OGM showcased at AMP 2025

2025-12-11T13:26:28.000Z - 9 months ago

Bionano Genomics recaps advances in OGM showcased at AMP 2025


Bionano Genomics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Bionano Genomics Earnings Call Transcript: Q3 2025


Bionano Genomics Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Bionano Genomics Quarterly report: Q3 2025


Bionano Genomics Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Bionano Genomics Earnings release: Q3 2025


Bionano Genomics Slides: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

Bionano Genomics Slides: Q3 2025


Bionano Genomics announces publication of study on OGM

2025-11-06T13:33:02.000Z - 10 months ago

Bionano Genomics announces publication of study on OGM


Bionano Genomics Transcript: H.C. Wainwright @ Home Event

Oct 15, 2025, 10:00 AM EDT - 11 months ago

Bionano Genomics Transcript: H.C. Wainwright @ Home Event


Bionano to Participate in the H.C. Wainwright @ Home Event

Oct 7, 2025, 8:00 AM EDT - 11 months ago

Bionano to Participate in the H.C. Wainwright @ Home Event


Bionano Genomics Registration statement: Registration Filing

Sep 11, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Registration statement: Registration Filing


Bionano Genomics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q2 2025


Bionano Genomics Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Quarterly report: Q2 2025


Bionano Genomics Earnings release: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings release: Q2 2025


Bionano Genomics Slides: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Slides: Q2 2025


Bionano Genomics Transcript: AGM 2025

Jun 11, 2025, 1:00 PM EDT - 1 year ago

Bionano Genomics Transcript: AGM 2025


Bionano Genomics Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q1 2025


Bionano Genomics Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Quarterly report: Q1 2025


Bionano Genomics Earnings release: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings release: Q1 2025


Bionano Genomics Slides: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Slides: Q1 2025


Bionano Genomics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing


Bionano Genomics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing


Bionano Genomics Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing


Bionano Genomics Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q4 2024


Bionano Genomics Annual report: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Annual report: Q4 2024


Bionano Genomics Earnings release: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings release: Q4 2024


Bionano Genomics Slides: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Slides: Q4 2024


Bionano Announces Effective Date of Reverse Stock Split

Jan 22, 2025, 4:05 PM EST - 1 year ago

Bionano Announces Effective Date of Reverse Stock Split


Bionano Genomics Transcript: EGM 2025

Jan 15, 2025, 1:00 PM EST - 1 year ago

Bionano Genomics Transcript: EGM 2025


Bionano Genomics Registration statement: Registration Filing

Jan 8, 2025, 7:00 AM EST - 1 year ago

Bionano Genomics Registration statement: Registration Filing


Bionano Genomics Registration statement: Registration Filing

Jan 3, 2025, 7:00 AM EST - 1 year ago

Bionano Genomics Registration statement: Registration Filing


Bionano Genomics Proxy statement: Proxy Filing

Dec 19, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing


Bionano Genomics Proxy statement: Proxy Filing

Dec 5, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing


Bionano Genomics Proxy statement: Proxy Filing

Dec 5, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing


Bionano Genomics Proxy statement: Proxy Filing

Nov 25, 2024, 7:00 AM EST - 1 year ago

Bionano Genomics Proxy statement: Proxy Filing


Bionano Genomics Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Earnings Call Transcript: Q3 2024


Bionano Genomics Quarterly report: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Quarterly report: Q3 2024


Bionano Genomics Earnings release: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Earnings release: Q3 2024


Bionano Genomics Slides: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Slides: Q3 2024


JumpStarting
JumpStarting Aug. 21 at 4:11 PM
$BNGO Another important development is reimbursement. CMS increased the 2026 payment determination associated with OGM testing for hematologic malignancies by 47%, improving the economics of clinical adoption. Can Bionano turn OGM into a recurring, increasingly reimbursed clinical testing platform with growing consumables utilization? This is a turnaround worth watching.
0 · Reply
JumpStarting
JumpStarting Aug. 21 at 4:04 PM
$BNGO The flow-cell numbers are particularly interesting. The Saphyr/OGM system is the equipment, but the flow cells are recurring consumables. If laboratories continue increasing their utilization of OGM, BNGO can potentially generate recurring revenue from an installed customer base rather than relying entirely on selling new instruments. And the opportunity isn't limited to one disease. OGM has applications in hematologic cancers, rare genetic disorders, muscular diseases, oncology research, reproductive genetics and cell/gene therapy.
0 · Reply
JumpStarting
JumpStarting Aug. 21 at 3:57 PM
$BNGO Is This the Beginning of the Turnaround? Q2 2026 showed: Revenue of $8.2M, up 21% year over year Consumables revenue of $4.3M, up 31% 9,219 flow cells sold, up 27% Existing-customer flow-cell purchases increased 24% Gross margin reached 53% BNGO fully retired its $20M secured convertible debt 2026 revenue guidance remains $31–33M
0 · Reply
vaccigen
vaccigen Aug. 20 at 12:30 AM
$BNGO Is the 5 cent hike to lure new investors?
1 · Reply
sloshua
sloshua Aug. 19 at 1:54 PM
0 · Reply
Dennizz
Dennizz Aug. 17 at 1:19 PM
$PGABF 🇺🇸 Could this be one of Europe’s most overlooked MedTech microcaps? $PGABF A tiny Swedish precision-medicine company Prostatype valued at only $5 million has developed a fully commercialized genomic test for prostate cancer, and is now awaiting a potentially transformational Medicare reimbursement decision in the U.S before year end🔥 $BNGO $INO $TNXP $ATOS.X
1 · Reply
juanagustin2086
juanagustin2086 Aug. 15 at 6:29 AM
1 · Reply
Marcobecco
Marcobecco Aug. 13 at 3:42 PM
0 · Reply
tokenhead
tokenhead Aug. 13 at 1:48 AM
$BNGO yes fuc ski boy..
0 · Reply
Snow120
Snow120 Aug. 12 at 6:09 PM
$BNGO where is motherfucking Erik? He is still CEO ???? Fuck him 🖕🏻🖕🏻🖕🏻🖕🏻
0 · Reply
JinUzuki
JinUzuki Aug. 11 at 7:37 PM
$BNGO There's no hope here. There's nothing that is going to push this back up higher.
0 · Reply
LeeSo
LeeSo Aug. 10 at 9:46 PM
$BNGO Out of my $71.2k investment, I can barely get a decent breakfast…!!! Lol $4500 a share is my average. I keep it as a souvenir! SMH 
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 10 at 9:25 PM
$BNGO Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.64 up 67.84% YoY • Reported revenue of -$6.67M down -199.10% YoY
0 · Reply
EarningsInsider
EarningsInsider Aug. 10 at 9:15 PM
https://www.marketbeat.com/earnings/reports/2026-8-10-bionano-genomics-inc-stock/ $BNGO Bionano Genomics Earnings Transcript
0 · Reply
Polymorpher
Polymorpher Aug. 10 at 8:50 PM
$BNGO Stable sales, strong demand, but manufacturing still not up to speed, creating limitations. Cash runway is still 1Q 2027.
0 · Reply
JinUzuki
JinUzuki Aug. 10 at 8:04 PM
$BNGO Earnings… and no one cares… amazing!
0 · Reply
JinUzuki
JinUzuki Aug. 8 at 1:21 PM
$BNGO FLYING!
0 · Reply
Caaron8695
Caaron8695 Aug. 4 at 10:23 PM
$BNGO i lost 30k with investing in BNGO! BUYERS BEWARE they will reverse split you to nothing not even worth the gamble I.M.O. Think im lying just go to the Max on all your stocks find out wich stocks have been reverse splitting not even worth the Time no longer holding reverse split stocks forward splits are the best
0 · Reply
JinUzuki
JinUzuki Aug. 4 at 2:14 PM
$BNGO I didn’t even notice, but this shit hit $1.00 on Friday!? BHAHAHAHAHA… that’s 0.00167c pre-splits…
0 · Reply
Peaceouty
Peaceouty Jul. 31 at 9:34 PM
$SPCX Around the end of next week you’re gonna have regrets. $BNGO
0 · Reply
JinUzuki
JinUzuki Jul. 31 at 1:40 PM
$BNGO This really is as bad as IBIO... what a fucking scam
0 · Reply
focafoca99
focafoca99 Jul. 27 at 8:26 PM
$BNGO to report Q2 2026 earnings on Aug 10 via webcast. https://www.rapidticker.com/news/bngo-bionano-to-report-second-quarter-eb443e
0 · Reply